ELOCOM 0.1% OINTMENT 30G

Indications

Approved Uses

Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (e.g., atopic dermatitis and psoriasis).

Dosage & Administration

Dosing by Condition

Corticosteroid-responsive dermatoses (including atopic dermatitis and psoriasis): apply a thin film to affected areas once daily; occlusion only if specifically prescribed for resistant lesions.

Initial Dose

Apply a thin film to the affected skin areas once daily.

Maintenance Dose

Apply once daily; reassess after 2-4 weeks; use minimum effective frequency for maintenance

Maximum Dose

Apply a thin layer once daily; use the smallest amount for the shortest duration and avoid large surface areas/occlusion (no fixed BSA maximum is universally specified).

Children's Dosage

Children 2 years and older: Apply thin layer to affected area once daily for up to 3 weeks. Not recommended in children under 2 years of age

Dose Adjustment Notes

Stop when control is achieved; if no improvement within ~2 weeks, reassess diagnosis/therapy; avoid prolonged continuous use and avoid/limit use on face/intertriginous areas; do not use occlusion unless directed; if frequent relapses, consider intermittent maintenance (e.g., 2 days/week) under clinician guidance.

How to Take

For topical use only: apply a thin film to affected skin once daily and rub in gently; wash hands before and after (unless treating hands); avoid eyes and mucous membranes and avoid use on face/groin/axillae unless directed; do not use occlusive dressings/bandages unless prescribed; use the smallest amount for the shortest duration needed.

Side Effects

Common Side Effects

Common local effects: burning/stinging/itching/irritation, dryness, erythema; less common but important with prolonged use: skin atrophy, striae, telangiectasia, folliculitis/furunculosis, acneiform eruptions, hypertrichosis, hypopigmentation, perioral dermatitis, allergic contact dermatitis, and secondary infection/miliaria (especially under occlusion).

Side Effect Frequency

Common: application-site burning/stinging, pruritus/itching, irritation/dryness; Uncommon: folliculitis/acneiform eruptions, skin atrophy, striae, telangiectasia, hypopigmentation, hypertrichosis, perioral dermatitis, allergic contact dermatitis, secondary infection/miliaria; Rare/very rare: HPA-axis suppression/Cushingoid effects (especially with occlusion/large areas/prolonged use), hyperglycemia, and ocular effects (glaucoma/cataract/blurred vision) with periocular use.

Safety & Warnings

Contraindications

Hypersensitivity to mometasone furoate or excipients; rosacea; perioral dermatitis; acne vulgaris; pruritus ani/genital pruritus; and untreated bacterial, fungal, or viral skin infections (e.g., herpes simplex, varicella).

Warnings & Precautions

Avoid eyes/mucous membranes and do not use for ophthalmic/oral/intravaginal use; avoid prolonged use on face/intertriginous areas and avoid occlusion unless directed; use the smallest amount for the shortest duration (especially in children) due to HPA-axis suppression/skin atrophy risk; discontinue if significant irritation occurs; if infection develops, treat appropriately and reassess steroid use; taper after prolonged use.

Age Restriction

Not recommended in children under 2 years of age.

Drug Interactions

Food Interaction

No known food interactions (not applicable for topical administration).

Special Populations

Children

Children 2 years and older: Apply thin layer to affected area once daily for up to 3 weeks. Not recommended in children under 2 years of age

Kidney Impairment

No adjustment needed

Storage & Patient Advice

Stopping the Medicine

If used for prolonged periods/large areas, do not stop abruptly-taper frequency/potency gradually under clinician guidance to reduce rebound/withdrawal and adrenal suppression risk.

Overdose

Acute topical overdose is unlikely; chronic excessive use (large area, prolonged duration, occlusion) can cause local atrophy and systemic effects (hypercortisolism/HPA-axis suppression). Management is to stop or taper as appropriate and provide supportive care; treat secondary infection if present.

Patient Counseling

Apply a thin layer to affected skin once daily as prescribed; avoid eyes/mucosa and wash hands after use (unless treating hands); do not use on face/groin/axillae or on broken/infected skin unless directed; avoid occlusive dressings/diapers unless instructed; use the smallest amount for the shortest duration and seek review if not improving within ~2 weeks or if irritation/infection occurs; do not abruptly stop after prolonged/large-area use-taper per prescriber advice.

Monitoring Requirements

No routine labs for short-term, limited-area use; monitor clinically for local adverse effects (atrophy, striae, telangiectasia, irritation) and secondary infection; for prolonged, large-area, pediatric, or occlusive use, periodically assess for HPA-axis suppression and systemic corticosteroid effects.

Pharmacology

Mechanism of Action

Binds intracellular glucocorticoid receptors to alter gene transcription, inducing lipocortins that inhibit phospholipase A2 and downstream arachidonic-acid mediator production (prostaglandins/leukotrienes), producing anti-inflammatory, antipruritic, and vasoconstrictive effects.

Product Information

Available Dosage Forms

Ointment, Cream, Lotion

Composition per Dose

Each gram of ointment: 1 mg mometasone furoate (0.1%) in a white petrolatum base

Generic Availability

Yes

OTC Alternatives

Hydrocortisone 1% topical (cream or ointment) as an OTC low‑potency corticosteroid alternative for mild inflammatory dermatoses (where locally available OTC).

Skin Condition

Eczema, Psoriasis, Allergic/Contact Dermatitis

Steroid Potency

Potent

Legal Disclaimer - Al Mujtama Pharmacy

The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Al Mujtama Pharmacy assumes no legal or medical liability for:

• Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
• Any discrepancy between the information provided and the product's package insert or SFDA guidelines
• Any misuse of medication resulting from personal interpretation of the content displayed

Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.

By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.

Your health is a trust - always consult your doctor first.